يعرض 1 - 10 نتائج من 33 نتيجة بحث عن '"Lysosomes / drug effects"', وقت الاستعلام: 1.06s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المؤلفون: Ivan Kodvanj, Jan Homolak

    المصدر: International Journal of Antimicrobial Agents

    وصف الملف: application/pdf

  4. 4

    المساهمون: Graduate School, Laboratory for General Clinical Chemistry, AGEM - Endocrinology, metabolism and nutrition, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Medical Biology, ANS - Cellular & Molecular Mechanisms, AGEM - Inborn errors of metabolism, Laboratory Genetic Metabolic Diseases, ACS - Diabetes & metabolism, APH - Aging & Later Life, ACS - Heart failure & arrhythmias

    المصدر: Journal of cell biology, 219(6):e201907067.. Rockefeller University Press
    The Journal of Cell Biology
    The Journal of Cell Biology, 219 (6)
    Journal of Cell Biology

    وصف الملف: application/pdf; application/application/pdf

  5. 5
  6. 6
  7. 7

    المساهمون: Graduate School, Medical Biochemistry, ACS - Diabetes & metabolism, ACS - Atherosclerosis & ischemic syndromes, AGEM - Endocrinology, metabolism and nutrition, Amsterdam Gastroenterology Endocrinology Metabolism, Landsteiner Laboratory, AII - Inflammatory diseases, Physiology, ICaR - Ischemia and repair

    المصدر: Journal of biological chemistry, 291(9), 4813-4825. American Society for Biochemistry and Molecular Biology Inc.
    Journal of Biological Chemistry, 291(9), 4813-4825. American Society for Biochemistry and Molecular Biology Inc.
    Nelson, J K, Cook, E C L, Loregger, A, Hoeksema, M A, Scheij, S, Kovacevic, I, Hordijk, P L, Ovaa, H & Zelcer, N 2016, ' Deubiquitylase Inhibition Reveals Liver X Receptor-independent Transcriptional Regulation of the E3 Ubiquitin Ligase IDOL and Lipoprotein Uptake ', Journal of Biological Chemistry, vol. 291, no. 9, pp. 4813-4825 . https://doi.org/10.1074/jbc.M115.698688

    مصطلحات موضوعية: 0301 basic medicine, Ubiquitin-Specific Proteases/antagonists & inhibitors, Transcription, Genetic, LDL/metabolism, Recombinant Proteins/chemistry, Biochemistry, Transcription, Genetic/drug effects, Mice, Ubiquitin, Genes, Reporter, Orphan Nuclear Receptors/genetics, Receptors, Transcriptional regulation, Receptors, LDL/genetics, Enzyme Inhibitors, Promoter Regions, Genetic, Ubiquitin-Protein Ligases/chemistry, Cells, Cultured, Liver X Receptors, Enzyme Inhibitors/pharmacology, Cultured, biology, Ubiquitination/drug effects, Recombinant Fusion Proteins/chemistry, Orphan Nuclear Receptors, Lipids, Recombinant Proteins, Ubiquitin ligase, Absorption, Physiological, Lipoproteins, LDL, Physiological/drug effects, lipids (amino acids, peptides, and proteins), Ubiquitin-Specific Proteases, Transcription, Absorption, Physiological/drug effects, Lysosomes/drug effects, Recombinant Fusion Proteins, Ubiquitin-Protein Ligases, Cells, Lipoproteins, Human Umbilical Vein Endothelial Cells/cytology, LDL/genetics, Absorption, Cell Line, Promoter Regions, 03 medical and health sciences, Lipoproteins, LDL/metabolism, Human Umbilical Vein Endothelial Cells, Animals, Humans, Liver X receptor, Molecular Biology, Post-transcriptional regulation, Transcription factor, Promoter Regions, Genetic/drug effects, Reporter, Genetic/drug effects, Ubiquitination, Proteolysis/drug effects, Cell Biology, 030104 developmental biology, Nuclear receptor, Receptors, LDL, Amino Acid Substitution, Genes, LDL receptor, Proteolysis, Mutation, biology.protein, Lysosomes

  8. 8

    المساهمون: Centre de Recherches en Cancérologie de Toulouse (CRCT), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Unité différenciation épidermique et auto-immunité rhumatoïde (UDEAR), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Toulouse [Toulouse], Institut Universitaire du Cancer de Toulouse - Oncopole (IUCT Oncopole - UMR 1037), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Necker - Enfants Malades [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Laboratoire de Pharmacocinétique et de Toxicologie clinique [Toulouse], Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Institut Fédératif de Biologie (IFB) - Hôpital Purpan, Hôpital Purpan [Toulouse], CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse]-Hôpital Purpan [Toulouse]

    المصدر: Clinical Immunology
    Clinical Immunology, Elsevier, 2018, 194, pp.75-79. ⟨10.1016/j.clim.2018.07.004⟩

  9. 9
    رسالة جامعية
  10. 10